✦ LIBER ✦

Effective therapy of aplastic anaemia post-hepatitis with recombinant human erythropoietin

✍ Scribed by Caterina Musolino; Annunziata Orlando; Andrea Alonci; Maria Concetta Santoro; Giacomo Bellomo; Melchiorre Quartarone; Giuseppe Squadrito

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 184 KB
Volume: 46
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830460114

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effective therapy of human immunodeficie

Effective therapy of human immunodeficiency virus-associated anemia with recombinant human erythropoietin despite high endogenous erythropoietin

✍ Noshir A. Dacosta; Mae B. Hultin 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 1 views

Combination Therapy With Recombinant Hum

Combination Therapy With Recombinant Human Granulocyte Colony-Stimulating Factor and Erythropoietin in Aplastic Anemia

✍ Dr. Masahiro Imamura; Masanobu Kobayashi; Sumiko Kobayashi; Kohki Yoshida; Chika 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB 👁 1 views

## Abstract Recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) and erythropoietin (rhEPO) were used to treat patients with aplastic anemia (AA). In terms of effects on erythrocyte recovery, the combined use of rhG‐CSF and rhEPO showed a favorable response in 6 of 14 (42.9%) patients

Anemia associated with advanced prostati

Anemia associated with advanced prostatic adenocarcinoma: Effects of recombinant human erythropoietin

✍ Beshara, Soheir; Letocha, Henry; Linde, Torbjörn; Wikström, Björn; Sandhagen, Bo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

## BACKGROUND AND METHODS. Nine patients with hormone-refractory metastatic prostatic adenocarcinoma and anemia were treated with recombinant human erythropoietin (rHuEpo) at a median dose of 150 U/kg BW 3 times a week subcutaneously. Baseline hemoglobin (Hb) ranged from 70 to 116 g/L, and the stu

Treatment of severe aplastic anemia with

Treatment of severe aplastic anemia with an immunosuppressive agent plus recombinant human granulocyte-macrophage colony-stimulating factor and erythropoietin

✍ Zonghong Shao; Yulin Chu; Yizhi Zhang; Guibin Chen; Yizhou Zheng 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 1 views

To evaluate the therapeutic potential of hematopoietic growth factors (HGFs) during immunosuppressive treatment (IST) of severe aplastic anemia (SAA), 38 patients with newly diagnosed SAA received IST alone (group I), or IST plus recombinant human erythropoietin and granulocyte-macrophage colony-sti

Effect of androgen therapy and anemia on

Effect of androgen therapy and anemia on serum erythropoietin levels in patients with aplastic anemia and myelodysplastic syndromes

✍ Piedras, Josefa; Hernández, Guadalupe; López-Karpovitch, Xavier 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 2 views

Immunoreactive serum erythropoietin (EPO) was measured in anemic and non-anemic patients with acquired non-severe aplastic anemia (AA; n = 22) and myelodysplastic syndromes (MDS; n = 31) receiving or not androgens to examine the effect of androgen therapy and anemia on EPO levels in these disorders.

Antiviral effect of human recombinant in

Antiviral effect of human recombinant interleukin-12 in patients infected with hepatitis C virus

✍ Lee, Jung-Hun; Teuber, Gerlinde; von Wagner, Michael; Roth, Willi Kurt; Zeuzem, 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB 👁 1 views

The heterogeneity of hepatitis C virus (HCV) is due to the continuous and high replication rate, the low fidelity of the RNA-dependent RNA polymerase, and the immune surveillance of the host. Interleukin-12 (IL-12) plays a central role in mounting an effective cellular immune response directed towar